Ignite Creation Date:
2025-12-24 @ 9:56 PM
Ignite Modification Date:
2026-01-09 @ 12:58 PM
Study NCT ID:
NCT06533332
Status:
RECRUITING
Last Update Posted:
2025-09-18
First Post:
2024-07-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors
Sponsor:
EtiraRx Australia Pty Ltd
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ERX-315-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None